[go: up one dir, main page]

WO2000003009A3 - Genes pour la biosynthese d'anticapsine et de bacilysine, leur isolement et leur utilisation - Google Patents

Genes pour la biosynthese d'anticapsine et de bacilysine, leur isolement et leur utilisation Download PDF

Info

Publication number
WO2000003009A3
WO2000003009A3 PCT/DE1999/002179 DE9902179W WO0003009A3 WO 2000003009 A3 WO2000003009 A3 WO 2000003009A3 DE 9902179 W DE9902179 W DE 9902179W WO 0003009 A3 WO0003009 A3 WO 0003009A3
Authority
WO
WIPO (PCT)
Prior art keywords
bacilysine
anticapsin
biosynthesis
genes
isolation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/DE1999/002179
Other languages
German (de)
English (en)
Other versions
WO2000003009A2 (fr
Inventor
Gerhard Steinborn
Juergen Hofemeister
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut fuer Pflanzengenetik und Kulturpflanzenforschung
Original Assignee
Institut fuer Pflanzengenetik und Kulturpflanzenforschung
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut fuer Pflanzengenetik und Kulturpflanzenforschung filed Critical Institut fuer Pflanzengenetik und Kulturpflanzenforschung
Priority to EP99947209A priority Critical patent/EP1097214A2/fr
Priority to AU60774/99A priority patent/AU6077499A/en
Priority to CA002334079A priority patent/CA2334079A1/fr
Publication of WO2000003009A2 publication Critical patent/WO2000003009A2/fr
Publication of WO2000003009A3 publication Critical patent/WO2000003009A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)

Abstract

L'invention concerne des gènes pour la biosynthèse de l'anticapsine et de la bacilysine, leur isolement et leur utilisation, notamment dans le domaine de la médecine et de l'agriculture. Il s'agit de préférence de produits géniques qui s'utilisent généralement comme antagonistes de la synthèse de la glucosamine et peuvent être utilisés comme moyens pour l'antibiose contre des agents pathogènes et saprogènes microbiens.
PCT/DE1999/002179 1998-07-10 1999-07-12 Genes pour la biosynthese d'anticapsine et de bacilysine, leur isolement et leur utilisation Ceased WO2000003009A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP99947209A EP1097214A2 (fr) 1998-07-10 1999-07-12 Genes pour la biosynthese d'anticapsine et de bacilysine, leur isolement et leur utilisation
AU60774/99A AU6077499A (en) 1998-07-10 1999-07-12 Genes for the biosynthesis of anticapsin and bacilysine, their isolation and their use
CA002334079A CA2334079A1 (fr) 1998-07-10 1999-07-12 Genes pour la biosynthese d'anticapsine et de bacilysine, leur isolement et leur utilisation

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19830912.0 1998-07-10
DE19830912 1998-07-10
DE19921807.2 1999-05-11
DE19921807 1999-05-11

Publications (2)

Publication Number Publication Date
WO2000003009A2 WO2000003009A2 (fr) 2000-01-20
WO2000003009A3 true WO2000003009A3 (fr) 2000-05-04

Family

ID=26047325

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE1999/002179 Ceased WO2000003009A2 (fr) 1998-07-10 1999-07-12 Genes pour la biosynthese d'anticapsine et de bacilysine, leur isolement et leur utilisation

Country Status (5)

Country Link
EP (1) EP1097214A2 (fr)
AU (1) AU6077499A (fr)
CA (1) CA2334079A1 (fr)
DE (1) DE19932908A1 (fr)
WO (1) WO2000003009A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2511553C (fr) 2002-12-26 2013-07-30 Shin-Ichi Hashimoto Procede de production d'un dipeptides
EP1767628A4 (fr) * 2004-06-25 2008-08-27 Kyowa Hakko Kogyo Kk Methode de production de dipeptide ou de derive de dipeptide
DE602005017707D1 (de) * 2004-06-25 2009-12-31 Kyowa Hakko Bio Co Ltd Verfahren zur Herstellung von Dipeptiden oder Dipeptidderivaten.
DE602005022387D1 (de) * 2004-06-25 2010-09-02 Kyowa Hakko Bio Co Ltd Verfahren zur Herstellung von Dipeptiden
EP2179652B1 (fr) 2008-09-10 2019-05-08 ABiTEP GmbH Gesellschaft für AgroBioTechnische Entwicklung und Produktion Utilisation d'un agent antibactérien pour le traitement des infections bactériennes chez les plantes cultivées
CN112226437B (zh) * 2020-10-26 2022-02-15 湖北大学 梯度调控芽胞杆菌启动子启动效率的序列组合及应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19654841A1 (de) * 1996-12-31 1998-07-02 Inst Pflanzengenetik & Kultur Zweifach positiv selektive Klonierungsvektoren

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19654841A1 (de) * 1996-12-31 1998-07-02 Inst Pflanzengenetik & Kultur Zweifach positiv selektive Klonierungsvektoren

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
GLASER ET AL.: "B. subtilis genomic region (325 to 333)", EMBL SEQUENCE DATABASE, 2 November 1993 (1993-11-02), HEIDELBERG DE, XP002132174 *
GLASER ET AL.: "Bacillus subtilis genome project: cloning and sequencing of the 97 kb region from 325° to 333°", MOLECULAR MICROBIOLOGY, vol. 10, no. 2, 1993, pages 371 - 384, XP002105658 *
KUNST ET AL.: "Bacillus subtilis complete genome (section 20 of 21): from 3798401 to 4010550", EMBL SEQUENCE DATABASE, 20 November 1997 (1997-11-20), HEIDELBERG DE, XP002132175 *
KUNST ET AL.: "The complete genome sequence of the Gram-positive bacterium Bacillus subtilis", NATURE, vol. 390, 20 November 1997 (1997-11-20), pages 249 - 256, Table 01, XP002080813, ISSN: 0028-0836 *

Also Published As

Publication number Publication date
WO2000003009A2 (fr) 2000-01-20
CA2334079A1 (fr) 2000-01-20
DE19932908A1 (de) 2000-01-20
AU6077499A (en) 2000-02-01
EP1097214A2 (fr) 2001-05-09

Similar Documents

Publication Publication Date Title
HK1047109A1 (zh) 作为指定基因干预工具的rna干预轨迹基因
WO2006013441A3 (fr) Utilisation de bacteries probiotiques dans la preparation de compositions topiques destinees a la protection de la peau
UA86413C2 (ru) Сахарное покрытие и твердая дозированая форма, которая его содержит
WO2005060709A3 (fr) Procede d'utilisation de bifidobacteries probiotiques pour des animaux de compagnie
BRPI0409228A (pt) materiais contendo fibra dietética melhorada compreendendo glucan de peso molecular baixo
AU2119200A (en) Medicament
TW200514786A (en) Novel diazabicyclononene derivatives
WO2000074662A3 (fr) Traitement de l'arthrite
WO2008033520A3 (fr) Séquences géniques de bifidobactéries et leur utilisation
WO2002024883A3 (fr) Bacteries d'acide lactique pouvant reduire la tendance d'un individu a developper des reactions allergiques
WO2007031319A8 (fr) Compositions comprenant des oligonucleotides d'arn a immunostimulation et procedes pour produire lesdits oligonucleotides d'arn
WO2002070464A3 (fr) Nouvelles hydrazones
WO2004096116A3 (fr) Derives de diazabicyclononene
WO2002030941A3 (fr) Inhibiteurs des topo-isomerases
WO2003012051A3 (fr) Inhibiteur de methylation d'adn
WO2000003009A3 (fr) Genes pour la biosynthese d'anticapsine et de bacilysine, leur isolement et leur utilisation
AU4414400A (en) Lactic acid bacteria with anxiolytic properties and uses thereof
WO2000040232A3 (fr) Nouvelles compositions et trousses de bretylium, et leur utilisation dans la prevention et le traitement des pathologies cardio-vasculaires
PL346143A1 (en) Tan-1057 derivatives
WO2004006911A3 (fr) Compositions destinees au traitement des neuropathies peripheriques, preparation et utilisations
BR0012973B1 (pt) Uso de bactéria do ácido láctico pertencente ao gênero Bifidobacterium, e composição alimentícia ou farmacêutica.
WO2004048393A3 (fr) Inhibiteurs de ?eta-lactamase
WO2007006521A3 (fr) Mélanges nutritionnels à efficacité élevée et accrue
WO2005012210A3 (fr) Preparations a activite antimicrobienne
WO2004083155A3 (fr) Derives d'esters lipidiques nucleotidiques

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AU AZ BA BB BG BR BY CA CN CU CZ EE GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LV MD MG MK MN MW MX NO NZ PL RO RU SD SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AU AZ BA BB BG BR BY CA CN CU CZ EE GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LV MD MG MK MN MW MX NO NZ PL RO RU SD SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

ENP Entry into the national phase

Ref document number: 2334079

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 60774/99

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 1999947209

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 09743443

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 1999947209

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: CA

WWW Wipo information: withdrawn in national office

Ref document number: 1999947209

Country of ref document: EP